YDES
YD Bio LtdNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$336.45M
P/E Ratio
—
EPS
$-0.12
Beta
-0.06
52W High
$25.00
52W Low
$4.37
50-Day MA
$5.90
200-Day MA
$11.06
Dividend Yield
—
Profit Margin
-276.60%
Forward P/E
—
PEG Ratio
—
About YD Bio Ltd
Breeze Holdings Acquisition Corp. The company is headquartered in Taipei, Taiwan.
Fundamentals
| Revenue (TTM) | 510,360 |
| Gross Profit (TTM) | 155,360 |
| EBITDA | $-1.36M |
| Operating Margin | -444.60% |
| Return on Equity | -42.70% |
| Return on Assets | -25.40% |
| Revenue/Share (TTM) | $0.47 |
| Book Value | $4.57 |
| Price-to-Book | 66.53 |
| Price-to-Sales (TTM) | 659.24 |
| EV/Revenue | 553.68 |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 95.60% |
| Shares Outstanding | $70.83M |
| Float | 319,870 |
| % Insiders | 81.01% |
| % Institutions | 0.49% |
Historical Volatility
HV 10-Day
58.93%
HV 20-Day
54.18%
HV 30-Day
55.83%
HV 60-Day
92.97%
HV Rank
—
Volatility is currently expanding
More HEALTHCARE Stocks
Data last updated: 5/25/2026